UB Paderborn / Katalog / Suche / in CDI

1 – 21 von 21

Sortiert nach

Is There Room for Liposomal Irinotecan in Biliary Tract Cancer? A Meta-analysis of Randomised Trials

Clinical oncology (Royal College of Radiologists (Great Britain)), 2024-02, Vol.36 (2), p.87-97

2024

Volltextzugriff (PDF)

Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling

International Journal of Obesity, 2018-03, Vol.42 (3), p.334-343

2018

Volltextzugriff (PDF)

P-26 Is there room for nal-IRI in biliary tract cancer?

Annals of oncology, 2023-06, Vol.34, p.S22-S22

2023

Volltextzugriff (PDF)

304P Clinical response to futibatinib in intrahepatic cholangiocarcinoma with acquired resistance to fibroblast growth factor receptor 2 inhibitors

Annals of oncology, 2024-06, Vol.35, p.S128-S129

2024

Volltextzugriff (PDF)

285P Gemcitabine, oxaliplatin and nab-paclitaxel as first-line treatment for patients with advanced biliary tract cancer: A multicenter, single-arm, phase I/II trial

Annals of oncology, 2024-06, Vol.35, p.S120-S120

2024

Volltextzugriff (PDF)

1620P A phase II study of perioperative nalirifox in patients with resectable pancreatic ductal adenocarcinoma (rPDAC): Survival update and biomarkers analysis of the NITRO trial

Annals of oncology, 2023-10, Vol.34, p.S897-S897

2023

Volltextzugriff (PDF)

337P Real-life second-line therapies outcome in metastatic pancreatic cancer (mPDAC) patients previously treated with gemcitabine plus nab-paclitaxel (Gem-Nab): An Italian multicenter study

Annals of oncology, 2024-06, Vol.35, p.S141-S141

2024

Volltextzugriff (PDF)

697P - Plasmatic CXCL8 is a marker for TGFß-activated kinase 1 (TAK1) activation which may predict resistance to nanoliposomal irinotecan (nal-IRI) in gemcitabine-refractory pancreatic cancer (PC) patients

Annals of oncology, 2019-10, Vol.30, p.v266-v266

2019

Volltextzugriff (PDF)

Plasmatic CXCL8 is a marker for TGFß-activated kinase 1 (TAK1) activation which may predict resistance to nanoliposomal irinotecan (nal-IRI) in gemcitabine-refractory pancreatic cancer (PC) patients

Annals of oncology, 2019-10, Vol.30, p.v266

2019

Volltextzugriff (PDF)

Intensive Neoadjuvant Chemoradiation Protocol for Locally Advanced Esophageal Cancer: Results in Real Life Population

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.e626-e627

2020

Volltextzugriff (PDF)

A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma

Annals of oncology, 2017-09, Vol.28, p.v27-v27

2017

Volltextzugriff (PDF)

697PPlasmatic CXCL8 is a marker for TGFß-activated kinase 1 (TAK1) activation which may predict resistance to nanoliposomal irinotecan (nal-IRI) in gemcitabine-refractory pancreatic cancer (PC) patients

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Clinicogenomic Analysis of FGFR2 -Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib

Cancer discovery, 2021-02, Vol.11 (2), p.326-339

2021

Volltextzugriff (PDF)

Diagnostics of T1279 ECMWF analysis winds in the Mediterranean basin by comparison with ASCAT 12.5 km winds

Quarterly journal of the Royal Meteorological Society, 2014-10, Vol.140 (685), p.2506-2514

2014

Volltextzugriff (PDF)

Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer

Journal for immunotherapy of cancer, 2021-03, Vol.9 (3), p.e002068

2021

Volltextzugriff (PDF)

Comparison of 10-m wind forecasts from a regional area model and quikSCAT scatterometer wind observations over the mediterranean sea

Monthly weather review, 2007-05, Vol.135 (5), p.1945-1960

2007

Volltextzugriff (PDF)

Using ASCAT Scatterometer Winds to Evaluate Relative Biases in the QuikSCAT-Derived Wind Vorticity

IEEE transactions on geoscience and remote sensing, 2012-07, Vol.50 (7), p.2518-2524

2012

Volltextzugriff (PDF)

Scatterometer and ECMWF‐derived wind vorticity over the Mediterranean Basin

Quarterly journal of the Royal Meteorological Society, 2013-04, Vol.139 (672), p.674-684

2013

Volltextzugriff (PDF)

The spatial structure of the Mediterranean Sea winds revealed by ERS-1 scatterometer

International journal of remote sensing, 2001-01, Vol.22 (1), p.45-70

2001

Volltextzugriff (PDF)

SAR based sea current estimation in the Naples coastal area

2016 IEEE International Geoscience and Remote Sensing Symposium (IGARSS), 2016, p.4665-4668

2016

Volltextzugriff (PDF)

HYDRO-POL - a spaceborne polarimetric radar-radiometer for land hydrology and ocean salinity

IEEE International Geoscience and Remote Sensing Symposium, 2002, Vol.3, p.1358-1360 vol.3

2002

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(19)
Tagungsberichte
(2)

Sprache

Englisch
(21)
Japanisch
(2)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Is There Room for Liposomal Irinotecan in Biliary Tract Cancer? A Meta-analysis of Randomised Trials

Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling

P-26 Is there room for nal-IRI in biliary tract cancer?

304P Clinical response to futibatinib in intrahepatic cholangiocarcinoma with acquired resistance to fibroblast growth factor receptor 2 inhibitors

285P Gemcitabine, oxaliplatin and nab-paclitaxel as first-line treatment for patients with advanced biliary tract cancer: A multicenter, single-arm, phase I/II trial

1620P A phase II study of perioperative nalirifox in patients with resectable pancreatic ductal adenocarcinoma (rPDAC): Survival update and biomarkers analysis of the NITRO trial

337P Real-life second-line therapies outcome in metastatic pancreatic cancer (mPDAC) patients previously treated with gemcitabine plus nab-paclitaxel (Gem-Nab): An Italian multicenter study

697P - Plasmatic CXCL8 is a marker for TGFß-activated kinase 1 (TAK1) activation which may predict resistance to nanoliposomal irinotecan (nal-IRI) in gemcitabine-refractory pancreatic cancer (PC) patients

Plasmatic CXCL8 is a marker for TGFß-activated kinase 1 (TAK1) activation which may predict resistance to nanoliposomal irinotecan (nal-IRI) in gemcitabine-refractory pancreatic cancer (PC) patients

Intensive Neoadjuvant Chemoradiation Protocol for Locally Advanced Esophageal Cancer: Results in Real Life Population

A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma

697PPlasmatic CXCL8 is a marker for TGFß-activated kinase 1 (TAK1) activation which may predict resistance to nanoliposomal irinotecan (nal-IRI) in gemcitabine-refractory pancreatic cancer (PC) patients

Clinicogenomic Analysis of FGFR2 -Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib

Diagnostics of T1279 ECMWF analysis winds in the Mediterranean basin by comparison with ASCAT 12.5 km winds

Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer

Comparison of 10-m wind forecasts from a regional area model and quikSCAT scatterometer wind observations over the mediterranean sea

Using ASCAT Scatterometer Winds to Evaluate Relative Biases in the QuikSCAT-Derived Wind Vorticity

Scatterometer and ECMWF‐derived wind vorticity over the Mediterranean Basin

The spatial structure of the Mediterranean Sea winds revealed by ERS-1 scatterometer

SAR based sea current estimation in the Naples coastal area

HYDRO-POL - a spaceborne polarimetric radar-radiometer for land hydrology and ocean salinity

Suchergebnisse filtern